Introducing international Investigators!

We are kicking off the new year with a juicy and powerful release – 150 000+ new clinical trials from regional and national clinical trials registries in Asia, Europe and North America!

Read more

Inhibition of negative immune regulation – The 2018 Nobel Prize in Physiology or Medicine

The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. In this weeks issue of 'Through the lens', we take a closer look at other leading stakeholders in the space of cancer related CTLA-4 and PD-1 research.

Read more

The leaders and people to watch for in the ctDNA space

The ctDNA space has attracted much attention lately due to its great potential as a blood-based biomarkers for early diagnosis, treatment and monitoring of cancers. In this weeks post, we outline the opinion leaders and rising stars in this space

Read more

Who's leading the way in Sickle cell disease?

Thanks to newborn screening, early blood transfusions and administering hydroxyurea in younger patients, most children born with Sickle cell disease today will survive to adulthood. But this improved care doesn’t cure the disease. This week, we take a closer look at the experts that are moving the needle in this space.

Read more

Half of the top 20 Big Pharma are now part of Monocl's customer portfolio!

We have grown rapidly over the past year. The key reason for our fast market uptake is related to the new approach we have taken to information in life science. Gone are the days when a siloed “source by source” analysis approach was sufficient to address challenging requirements and core customer needs – things are simply moving too fast today.

Read more

Top Investigators, established opinion leaders and rising stars within MS

This week, we look into the world of Multiple sclerosis and zero in on top Investigators as well as funding landscape and trends.

Read more